RhumbLine Advisers’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666K | Buy |
+59,230
| New | +$666K | ﹤0.01% | 2484 |
|
|
2024
Q3 | – | Sell |
-3,516
| Closed | -$47K | – | 4236 |
|
|
2024
Q2 | $47K | Sell |
3,516
-33,299
| -90% | -$445K | ﹤0.01% | 3702 |
|
|
2024
Q1 | $1.71M | Sell |
36,815
-5,041
| -12% | -$234K | ﹤0.01% | 1977 |
|
|
2023
Q4 | $2.83M | Buy |
41,856
+1,298
| +3% | +$87.7K | ﹤0.01% | 1729 |
|
|
2023
Q3 | $2.94M | Sell |
40,558
-84
| -0.2% | -$6.08K | ﹤0.01% | 1654 |
|
|
2023
Q2 | $3.02M | Buy |
40,642
+18,023
| +80% | +$1.34M | ﹤0.01% | 1680 |
|
|
2023
Q1 | $1.2M | Buy |
22,619
+1,425
| +7% | +$75.8K | ﹤0.01% | 2042 |
|
|
2022
Q4 | $1.43M | Buy |
21,194
+2,618
| +14% | +$177K | ﹤0.01% | 1957 |
|
|
2022
Q3 | $2.32M | Buy |
18,576
+36
| +0.2% | +$4.49K | ﹤0.01% | 1670 |
|
|
2022
Q2 | $1.77M | Buy |
18,540
+17,410
| +1,541% | +$1.66M | ﹤0.01% | 1829 |
|
|
2022
Q1 | $182K | Hold |
1,130
| – | – | ﹤0.01% | 2781 |
|
|
2021
Q4 | $376K | Buy |
+1,130
| New | +$376K | ﹤0.01% | 2624 |
|